Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

First Ascent Biomedical creates personalized cancer treatment plans by testing how a patient’s tumor and resistant cells respond to drugs and using AI to rank effective options. Their Drug Prediction…

First Ascent Biomedical creates personalized cancer treatment plans by testing how a patient’s tumor and resistant cells respond to drugs and using AI to rank effective options. Their Drug Prediction…
Headquarters: Miami, Florida
Founded: 2018
Focus: AI-driven personalized combination cancer therapy recommendations
Product: Drug Prediction Platform (DxPP) — ex vivo drug sensitivity testing + sequencing + causal ML
Recent funding: Announced $6M venture/seed round (Jan 13, 2025) plus 2025 grants
Personalized oncology treatment selection; resistance-informed combination therapy design.
2018
Biotechnology
$6,000,000
Reported venture/seed round announced Jan 13, 2025
Grant announced Mar 4, 2025
Grant announced Jun 5, 2025
“Includes venture investors (Vidal Duart Enterprises, Techstars) and grant funders (Florida Department of Health, Fight Colorectal Cancer); additional named investors include IAG Capital Partners and Secure Erie Accelerator.”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week